CEO: Urs Frey
Urs Frey is MaxWell Biosystems’ CEO, member of the founding team and serves as vice president on the company’s board of directors. Urs earned his PhD in Electrical Engineering at ETH Zurich where he innovated the “switch-matrix” architecture now commonly used in microelectrode arrays. Following, he moved to at IBM Research, where he did a postdoc on mixed-signal circuit design. Later, Urs was heading an independent laboratory focusing on CMOS-based bioelectronics and biosensors at RIKEN, Japan. Recently, Urs completed a management training at the University of St. Gallen (Diploma of Advanced Studies, Leadership Development Program).
CTO: Jan Müller
Jan Müller is MaxWell Biosystems’ CTO and a member of the founding team and serves as the president of the company’s board of directors. Jan is the expert in MEA technology and the inventor of our core 26,000 microelectrode array. Jan obtained his PhD from ETH Zurich (D-BSSE). He has an interdisciplinary background in computer science, electrical engineering, systems biology and computational neuroscience.
VP Marketing and Sales: Marie Engelene Obien
Marie Obien is Vice President Marketing and Sales, is a member of the founding team and serves as a member of the company’s board of directors. Marie is a specialist in electrophysiology, with strong skills in MEAs and various techniques, including the gold-standard electrophysiology method–patch-clamp. She is the author of the currently most frequently cited review on MEAs. Marie participated in the Global Innovation Program workshop for business development in the Silicon Valley. Marie earned her PhD in Electrical Engineering from NAIST, Japan, and obtained her training in neuroscience as a postdoctoral researcher at RIKEN, Japan.
VP Scientific Affairs: Michele Fiscella
Michele Fiscella is the Vice President Scientific Affairs, is a member of the founding team and serves as a member of the company’s board of directors. Michele has his main scientific background in biotechnology. During his PhD, he specialized in neuronal electrophysiology and ophthalmology applications, using high-density microelectrode array technology. Michele also gained experience in data analyses of biological large-scale datasets and modeling of neuronal signals. He discovered the physiological role of a gene involved in a human disease of vision, by MEA technology. Michele has a strong experience in management of scientific projects as well as partnering with companies and research institutes worldwide. Michele obtained his Master in Molecular and Industrial Biotechnology from University of Bologna and his PhD degree from ETH Zurich.
VP Operations: Marcel Suter
Marcel Suter is the Vice Present Operations. Marcel joined MaxWell Biosystems in 2020. Before that, he worked as project manager and later as VP Operations at Optotune, an optics company. As a member of Optotune Consumer Switzerland AG’s management team, he led their cost-efficient manufacturing of liquid lens products. Marcel has a strong expertise in establishing and improving processes for production ramp-up, and in ensuring high quality and on-time customer delivery. Marcel holds a Master in Micro- and Nanotechnology from University of Neuchâtel and a PhD in Micro- and Nanosystems at ETH Zurich. He gained a deeper knowledge in MEMS fabrication during his Master thesis at UC Berkeley.